Rationale
The Data Monitoring Committee (DMC) Initiative addresses the challenge of a limited and diminishing number of experienced candidates available for service on DMCs, in the face of increasing clinical trial monitoring needs. This initiative aims to identify a means of expanding clinical trial sponsors’ access to a broader pool of sufficiently skilled candidates when convening DMCs. As of November 2021, the Data Monitoring Committee Initiative is complete. There are no new deliverables or updates planned. The Society of Clinical Trials has implemented TransCelerate’s guidelines into a Data Monitoring Committee Registry and DMC Training Resource Library.
Benefits
- Enhance skills and number of candidates capable of serving on DMCs, benefiting both individuals desiring to serve on DMCs and sponsors searching for competent DMC members
- More options for sponsors in selecting DMC members
- Increase DMC candidate visibility to clinical trial sponsors (thus increasing opportunities to impact cutting-edge research)